Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation
- 1 February 1993
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 15 (2) , 175-183
- https://doi.org/10.1016/0192-0561(93)90093-e
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Depletion of macrophages expressing I-J antigen results in efficient generation of alloreactive cytotoxic T lymphocytesCellular Immunology, 1990
- Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatinCancer Immunology, Immunotherapy, 1989
- Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological propertiesJournal of Medicinal Chemistry, 1985
- Induction of Interferon and Activation of NK Cells and Macrophages in Mice by Oral Administration of Ge‐132, an Organic Germanium CompoundMicrobiology and Immunology, 1985
- Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast mediumCancer, 1984
- Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancsProtein Journal, 1984
- Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary reportEuropean Journal of Cancer and Clinical Oncology, 1983
- In vivo effect of anti-asialo GM1 antibody on natural killer activityNature, 1981
- A LIPOPHILIC DERIVATIVE OF NEOCARZINOSTATIN A Polymer Conjugation of an Antitumor Protein Antibiotic*International Journal of Peptide and Protein Research, 1979
- Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.The Journal of Experimental Medicine, 1975